MSB0011359C (M7824)

bintrafusp alfa · Merck KGaA

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MSB0011359C (M7824), covering 2024-05-03 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors [Phase 1]